Derivatives of A-21978C cyclic peptides
AssigneeEli Lilly and Company
InventorManuel Debono
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorManuel Debono
Estimating the term…
A-21978C cyclic peptide derivatives of the formula ##STR1## wherein R is hydrogen, a specified aminoacyl or N-alkanoylaminoacyl group, 8-methyldecanoyl, 10-methyldodecanoyl, 10-methylundecanoyl, the specific C.sub.10 -alkanoyl group of A-21978C.sub.0 or the specific C.sub.12 -alkanoyl groups of A-21978C factors C.sub.4 and C.sub.5 or an amino-protecting group; and R.sup.1 is hydrogen, an amino-protecting group, or a specified aminoacyl or N-alkanoylaminoacyl group; provided that, when R is other than aminoacyl or N-alkanoylaminoacyl, R.sup.1 must be aminoacyl or N-alkanoylaminoacyl; and, when R.sup.1 is an amino-protecting group, R must be aminoacyl or N-alkanoylaminoacyl; and the salts thereof, are useful as antibacterial agents or as intermediates to antibacterial agents.
An A-21978C cyclic peptide derivative of the formula:
The compound of claim wherein R is 2-[N-(n-dodecanoyl)amino]nicotinoyl and R.sup.1 is hydrogen.
Dependencies are inferred from the claim text.